Qiumei Yang

Person

Shanghai, CN

People

Patents Grantslast 30 patents

Information Patent Grant
Anti-CXCL13 antibodies for treating autoimmune diseases and cancer
- Patent number 12,145,982
- Issue date Nov 19, 2024
- I-MAB BIOPHARMA US LIMITED
- Haijuan Gu
- G01 - MEASURING TESTING
Information Patent Grant
Anti-CD73 anti-PD-L1 bispecific antibodies
- Patent number 11,034,771
- Issue date Jun 15, 2021
- I-MAB BIOPHARMA US LIMITED
- Zhengyi Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-CXCL13 antibodies
- Patent number 11,028,164
- Issue date Jun 8, 2021
- I-MAB BIOPHARMA US LIMITED
- Haijuan Gu
- G01 - MEASURING TESTING
Information Patent Grant
Treatment of cancer using a CLL-1 chimeric antigen receptor
- Patent number 10,568,947
- Issue date Feb 25, 2020
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ANTI-CXCL13 ANTIBODIES FOR TREATING AUTOIMMUNE DISEASES AND CANCER
- Publication number 20210284724
- Publication date Sep 16, 2021
- I-MAB Biopharma US Limited
- Haijuan Gu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTISPECIFIC MOLECULES TARGETING CLL-1
- Publication number 20210198368
- Publication date Jul 1, 2021
- Novartis AG
- Michael DALEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CXCL13 ANTIBODIES FOR TREATING AUTOIMMUNE DISEASES AND CANCER
- Publication number 20200399360
- Publication date Dec 24, 2020
- I-MAB Biopharma US Limited
- Haijuan Gu
- G01 - MEASURING TESTING
Information Patent Application
ANTI-CD73 ANTI-PD-L1 BISPECIFIC ANTIBODIES
- Publication number 20200347146
- Publication date Nov 5, 2020
- I-MAB Biopharma US Limited
- Zhengyi Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF CANCER USING A CLL-1 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20200215171
- Publication date Jul 9, 2020
- Novartis AG
- Jennifer Brogdon
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHOSPHOGLYCERATE KINASE 1 (PGK) PROMOTERS AND METHODS OF USE FOR EX...
- Publication number 20180118834
- Publication date May 3, 2018
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF CANCER USING A CLL-1 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20160051651
- Publication date Feb 25, 2016
- The Trustees of the University of Pennsylvania
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Qiumei Yang

Person

Patents Grantslast 30 patents

Anti-CXCL13 antibodies for treating autoimmune diseases and cancer

Anti-CD73 anti-PD-L1 bispecific antibodies

Anti-CXCL13 antibodies

Treatment of cancer using a CLL-1 chimeric antigen receptor

Patents Applicationslast 30 patents

ANTI-CXCL13 ANTIBODIES FOR TREATING AUTOIMMUNE DISEASES AND CANCER

MULTISPECIFIC MOLECULES TARGETING CLL-1

ANTI-CXCL13 ANTIBODIES FOR TREATING AUTOIMMUNE DISEASES AND CANCER

ANTI-CD73 ANTI-PD-L1 BISPECIFIC ANTIBODIES

TREATMENT OF CANCER USING A CLL-1 CHIMERIC ANTIGEN RECEPTOR

PHOSPHOGLYCERATE KINASE 1 (PGK) PROMOTERS AND METHODS OF USE FOR EX...

TREATMENT OF CANCER USING A CLL-1 CHIMERIC ANTIGEN RECEPTOR